Markets often feel most confusing right before clarity returns. March is shaping up to be one of those periods—where surface-level indecision hides meaningful alignment underneath. Capital is flowing toward structural growth, supply-constrained infrastructure, and competitive inflection points, not speculative headlines. Names like Advanced Micro Devices and Micron Technology reflect that shift, but they’re only part of a broader roadmap. For investors without time to micromanage trades, understanding why capital is positioning matters far more than reacting to price moves.

At the end, we tie all five names into a single framework designed for clarity, not clutter. Read the full newsletter to see why March rewards alignment—not urgency.

Let’s embark on this transformative journey together and position your portfolio for success in this evolving market landscape!

Be sure to read through to the end to catch all the valuable insights this newsletter delivers to your inbox today.

Picture this: Five years ago, Intuitive Surgical $ISRG ( ▲ 0.24% ) stock sat around $238 per share. Today in late February 2026, it closes at $503.51 for a clear +112% rise. The chart shows a steady climb with a few pauses, powered by growing use of advanced medical tools in hospitals worldwide. The 52-week high reached $603.88, showing the stock can push much higher in strong periods.

Breaking it down simply: The compound annual growth rate (CAGR) comes to about 16%. That’s the average yearly increase built from the ending value divided by the starting value raised to 1/5 minus 1. If the pace holds, it means reliable yearly progress that adds up over time.

Picture yourself using dollar-cost averaging (DCA): adding $500 each month for the next five years no matter the daily price. That adds up to $30,000 total from your pocket over 60 months. You end up buying more shares on softer days and fewer on stronger ones, which keeps your average cost balanced.

Imagine waking up Monday being pulled out of bed — not needing to pushing yourself out of it.

That pull isn't motivation. It isn't willpower. It's what happens when Tony Robbins conditions a different identity into your nervous system.  An identity doesn't wait, doesn't hesitate, doesn't negotiate with itself.

That's what Unleash the Power Within does. It’s not inspiration. It’s Conditioning. The patterns that keep you hesitating, shrinking, and circling the same problems — Tony interrupts them at the root and installs new ones. You don't leave motivated. You leave re-wired differently.

4 days. Virtual. March 12–15. 5 million people across 195 countries have done this. It’s your time. 

Save $100 by getting a ticket before March 6th. After that the price goes up. But the real cost is another year pushing instead of being pulled.

Ready to Rewire? Register Now.

Assuming ISRG follows a similar historical pace around that 16% annual growth, each monthly $500 grows based on the time left. By the end of five years, your investment could reach roughly $44,000 to $45,000. That delivers a gain of about $14,000 to $15,000 beyond what you put in—a solid 47–50% overall return from regular, hands-off investing.

Past patterns do not guarantee what comes next—healthcare rules, new tech, or market shifts can change things. But ISRG leads the field in robotic-assisted surgery with its da Vinci systems, keeping the long-term picture bright. Your $500 monthly commitment stays easy to handle while time and steady growth do the rest.

Medical tech trends and better patient results often give companies like this extra support for years. Staying consistent even during quieter stretches is what turns simple saving into stronger outcomes.

Ready to move ahead with this plan?

March is arriving with familiar tension. Earnings season is fading, volatility has not fully resolved, and markets remain suspended between anticipation and hesitation. The surface-level noise suggests indecision. Beneath it, something more constructive is happening.

This is a consolidation phase—not stagnation.

Capital is rotating, not retreating. Sector leadership is shifting while investors wait for the next wave of 2026 catalysts to assert themselves. The data stream continues to affirm growth, but the market wants confirmation before committing aggressively.

That hesitation creates opportunity—particularly for investors who do not have the luxury of watching markets minute by minute.

This month’s selections are not about chasing momentum or guessing headlines. They reflect a deliberate mix of:

Each name serves a distinct purpose. Together, they form a roadmap through uncertainty—designed for someone who needs clarity, not clutter.

This is the most speculative name on the list—and intentionally so.

Aeluma operates at the intersection of compound semiconductors, photonics, and advanced manufacturing processes, all of which are critical to next-generation AI systems. Unlike traditional silicon-only chips, compound semiconductors integrate materials such as silicon carbide, enabling higher efficiency, greater bandwidth, and lower latency.

Photonics—the use of light and lasers to transmit data—is a cornerstone of future AI architecture. It allows massive data movement at speeds electrical systems cannot match.

Why has Aeluma not surged like other photonics names?

Because this is still early-stage commercialization.

The technology has been validated. The balance sheet is strong. Analysts are aligned. What remains is manufacturing adoption. Aeluma is not simply selling chips—it is proposing a manufacturing revolution, which takes time to gain industry-wide traction.

Recent news flow suggests that traction is forming. The chart reflects a bottoming pattern with upward momentum. For 2026, this is not a revenue story yet—it is a capability story approaching inflection.

This name stands apart from the rest—and that is precisely the point.

e.l.f. Beauty is not an innovation bet; it is a recovery driven by execution. The stock suffered last year due to margin concerns tied to tariffs and uneven product rollouts. Importantly, the business itself did not deteriorate—the market simply ran ahead of fundamentals.

That imbalance has now corrected.

Recent earnings confirmed:

Tariff impacts proved less severe than feared. Product execution improved. Expansion into Europe—particularly with newer brands—showed strong traction.

Analyst sentiment, while still mixed, is tightening around higher targets. The trend is no longer downward—it is stabilizing and improving.

This is a buy-the-dip opportunity, not a turnaround gamble. Consumer demand remains intact. Valuation has reset. Growth visibility has returned.

Markets are no longer reacting primarily to earnings and rates.

Global investor surveys report geopolitical conflict and policy swings now rank above recessions as the biggest threats to portfolios.

That means higher risk premiums across equities, bonds, and FX. In plain English: you may be taking more risk for less upside.

So what have sophisticated investors done differently for decades?

They diversify with assets that are priced globally and historically appreciate independently of traditional markets.

One typically exclusive to the ultra wealthy? Postwar and contemporary art.

It’s shown low correlation to stocks, global demand, and resilience during political shocks.*

And now it’s easy to fractionally invest in multimillion dollar art featuring Banksy, Basquiat and more, thanks to Masterworks.

Investors have seen net annualized returns like 14.6%, 17.6%, and 17.8% across 26 exits.

See how to add political-risk insulation to your portfolio at Masterworks:

Skip waitlist

_{*Investing involves risk. Past performance not indicative of future returns. See important disclosures at masterworks.com/cd.}

Amprius has been a waiting game—and that wait is nearing resolution.

The company produces high-density, lightweight batteries that dramatically improve drone range, payload, and efficiency. This is not theoretical technology. It works. It is shipping. Orders exist.

The strategic shift that matters most: Amprius moved away from building its own manufacturing facilities and transitioned into a contract manufacturing model. This unlocked scale, reduced capital risk, and accelerated partnerships.

Key developments:

The drone market itself is expanding globally, with countries racing to domesticate production. Amprius sits squarely in the middle of that demand.

Analysts remain highly bullish, with recent price target revisions pushing into the $18–$20 range, implying nearly 100% upside. The upcoming earnings report is expected to affirm guidance and reinforce momentum.

This is not hype. It is delayed recognition.

Micron’s inclusion is not speculative—it is structural.

The stock recently broke out of consolidation, signaling trend continuation. The driver is unmistakable: AI memory demand.

High Bandwidth Memory (HBM) is sold out through the end of this year—and increasingly expected to remain constrained well into next year. Every AI accelerator requires multiple stacks of HBM. Demand is not only strong; pricing power is strengthening.

Key forces at work:

Concerns about overproduction miss the longer arc. Data centers have expanded permanently. Hardware refresh cycles are inevitable. HBM4 is approaching, followed by HBM5. Each generation increases memory intensity.

This is not a one-cycle story. It is a compounding one.

At the top sits the most consequential catalyst of the month.

AMD’s upcoming MI450 accelerators and Helios Rackscale solutions, launching in the second half of the year, are reshaping competitive assumptions. These are not incremental products—they are system-level solutions.

Momentum is already visible:

The long-standing debate—whether AMD can truly compete with Nvidia—is no longer theoretical. Major hyperscalers are buying from both.

Analysts are steadily lifting targets:

AMD is no longer chasing relevance. It is scaling dominance.

This market does not reward reaction. It rewards preparation.

Each name here reflects a different way capital moves:

For someone balancing limited time with long-term ambition, the message is simple:

March is not about predicting the next headline.
It is about aligning with where growth is already forming.

And letting the market catch up later.

Ready to Revolutionize Your Wealth?

Here's what's waiting for you:

As the world becomes increasingly digital, this question will be on the minds of millions seeking new income streams in 2026.

The answer is—Absolutely!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every day. 

 What do you think of the new format? Please provide your feedback in the poll below, and if you find the newsletter valuable, feel free to share it with other investors!

Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a financial advisor before making any investment decisions.